Tao Hou

7PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 25, 2026
Becotatug Vedotin Combined With Pucotenlimab in Platinum- and Immunotherapy-Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma.

|Apr 22, 2024
Predicting the overall survival and progression-free survival of nasopharyngeal carcinoma patients based on hemoglobin, albumin, and globulin ratio and classical clinicopathological parameters.

Zui Chen, Jie Ling, Sujuan Zhang

|Mar 05, 2024
Nomograms based on the lymphocyte-albumin-neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive radiotherapy.

Sujuan Zhang, Zui Chen, Jie Ling

|Nov 23, 2023
Prognostic value of the fibrinogen albumin ratio index (FARI) in nasopharyngeal carcinoma patients undergoing radiotherapy.

Chao Deng, Sujuan Zhang, Jie Ling

|Apr 25, 2022
High fibrinogen-albumin ratio index (FARI) predicts poor survival in head and neck squamous cell carcinoma patients treated with surgical resection.

Sisi Wang, Yuhua Feng, Yangchun Xie

|Feb 26, 2021
Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIs.

Shun Jiang, Sisi Wang, Qianqian Wang

Pageof 2

Frequent Collaborators

1 joint publications

Chunhong Hu

1 joint publications

Zui Chen

1 joint publications

Yanqun Xiang

1 joint publications

Linquan Tang